Buyout (LBO, MBO, MBI) • Environmental

GPB Capital Acquires Buckeye Water Service

On August 1, 2017, asset manager GPB Capital acquired environmental company Buckeye Water Service

Acquisition Context
  • This is GPB Capital’s 3rd transaction in the Environmental sector.
  • This is GPB Capital’s 7th transaction in the United States.
  • This is GPB Capital’s 1st transaction in Ohio.

Explore All 379 Buyout (LBO, MBO, MBI) Environmental Deals - Search the Database Free


M&A Deal Summary

Date August 1, 2017
Target Buckeye Water Service
Sector Environmental
Buyer(s) GPB Capital
Deal Type Buyout (LBO, MBO, MBI)

Target Company

Buckeye Water Service

New Concord, Ohio, United States
Buckeye Water Service provides fluid hauling and storage, oilfield trucking and equipment, roll-off container, and solid waste removal services to customers engaged in drilling and development in the Utica and Marcellus shales. Buckeye Water Service was founded in 1996 and is based in New Concord, Ohio.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

GPB Capital

Investor


Category Asset Manager
Founded 2013
PE ASSETS 1.5B USD
Size Large
Type Sector Agnostic
DESCRIPTION

GPB Capital is an asset management firm focused on acquiring income-producing private companies. Sectors of interest include automotive, retail, technology enabled services, waste management, and healthcare. GPB Capital was established in 2013 and is headquartered in New York City.


Deal Context for Buyer #
Overall 7 of 11
Sector: Environmental 3 of 3
Type: Buyout (LBO, MBO, MBI) 4 of 7
State: Ohio 1 of 1
Country: United States 7 of 11
Year: 2017 4 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-07-27 Staten Island Carting

Staten Island, New York, United States

Staten Island Carting is a private waste management company based in Staten Island, New York.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-01-18 EMI

Torrance, California, United States

EMI is a developer of treatments and therapies for rare and orphan diseases. The company's research on sickle cell disease was initiated by Yutaka Niihara, MD, MPH, Chairman and CEO of Emmaus, at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. EMI was founded in 2000 and is based in Torrance, California.

Buy -